Information  X 
Enter a valid email address

Episode Inc (IRSH)

  Print      Mail a friend

Friday 14 June, 2019

Episode Inc

Appointment of Director

RNS Number : 3769C
Episode Inc
14 June 2019
 

STOCK EXCHANGE ANNOUNCEMENT

 

For Immediate Release                                                                               14 June, 2019

 

 

Episode Inc.

 

Re: Appointment of Director

 

The Directors of Episode Inc. (the "Fund") wish to announce the appointment of John Le Poidevin as an Independent Director of the Fund, with effect from 14 June 2019.

 

John Le Poidevin

 

Mr Le Poidevin has over 25 years' business experience as an auditor and adviser to listed and large private companies in the UK and global markets. He is a former partner of BDO LLP in London, where as Head of Consumer Markets he developed an extensive breadth of experience and knowledge of corporate governance, financial reporting and risk management. Since 2013 he has been acting in a non-executive director capacity for a number of listed and unlisted funds and corporates, primarily in the role of Audit Committee Chair. 

 

John Le Poidevin has never:

 

(i)   had any unspent convictions in relation to indictable offences; or

(ii)  been a director of any company or partnership which, while he was a director with an executive function or partner at the time of or within the 12 months preceding such events, been declared bankrupt, went into receivership, liquidation, administration or voluntary arrangements; or

(iii) been subject to any official public incrimination and/or sanctions by statutory or regulatory authorities (including designated professional bodies); or been disqualified by a court from acting as a director of a company or from acting in the management or conduct of affairs of any company.

 

 

 

Enquiries:

 

Investment Manager

Samantha Bower

+44 207 548 2259

 

 

 

Davy

Paul Boland

00353 1 617 3378

 

 

 

 

 

 

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISELLFIERIISLIA

a d v e r t i s e m e n t